ロード中...
Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection
Clostridioides difficile is the leading cause of nosocomial infections and a worldwide urgent public health threat. Without doubt, there is an urgent need for new effective anticlostridial agents due to the increasing incidence and severity of C. difficile infection (CDI). The aim of the present stu...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7206065/ https://ncbi.nlm.nih.gov/pubmed/32382070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-64882-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|